{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T04:10:30Z","timestamp":1744517430334,"version":"3.40.4"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["DSAIPA\/DS\/0117\/2020","UIDP\/00297\/2020","UIDB\/00297\/2020"],"award-info":[{"award-number":["DSAIPA\/DS\/0117\/2020","UIDP\/00297\/2020","UIDB\/00297\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005855","name":"Universidade Nova de Lisboa","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005855","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Identifying high-risk patients, particularly in intensive care units (ICUs), enhances treatment and reduces severe outcomes. Since the pandemic, numerous studies have examined COVID-19 patient profiles and factors linked to increased mortality. Despite six pandemic waves, to the best of our knowledge, there is no extensive comparative analysis of patients\u2019 characteristics across these waves in Portugal. Thus, we aimed to analyze the demographic and clinical features of 1041 COVID-19 patients admitted to an ICU and their relationship with the different SARS-Cov-2 variants in Portugal. Additionally, we conducted an in-depth examination of factors contributing to early and late mortality by analyzing clinical data and laboratory results from the first 72\u00a0h of ICU admission. Our findings revealed a notable decline in ICU admissions due to COVID-19, with the highest mortality rates observed during the second and third waves. Furthermore, immunization could have significantly contributed to the reduction in the median age of ICU-admitted patients and the severity of their conditions. The factors contributing to early and late mortality differed. Age, wave number, D-dimers, and procalcitonin were independently associated with the risk of early death. As a measure of discriminative power for the derived multivariable model, an AUC of 0.825 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001; 95% CI, 0.719\u20130.931) was obtained. For late mortality, a\u00a0model incorporating age, wave number, hematologic cancer, C-reactive protein, lactate dehydrogenase, and platelet counts resulted in an AUC of 0.795 (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001; 95% CI, 0.759\u20130.831). These findings underscore the importance of conducting comprehensive analyses across pandemic waves to better understand the dynamics of COVID-19.<\/jats:p>","DOI":"10.1007\/s11357-024-01410-x","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T02:43:29Z","timestamp":1731552209000},"page":"2399-2422","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of six consecutive waves of ICU-admitted COVID-19 patients: key findings and insights from a Portuguese population"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6843-1935","authenticated-orcid":false,"given":"Cristiana P.","family":"Von Rekowski","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2945-1441","authenticated-orcid":false,"given":"Iola","family":"Pinto","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0741-2211","authenticated-orcid":false,"given":"Tiago A. H.","family":"Fonseca","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9369-6486","authenticated-orcid":false,"given":"R\u00faben","family":"Ara\u00fajo","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5264-9755","authenticated-orcid":false,"given":"Cec\u00edlia R. C.","family":"Calado","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0260-003X","authenticated-orcid":false,"given":"Lu\u00eds","family":"Bento","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"key":"1410_CR1","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jiph.2020.03.019","volume":"13","author":"H Harapan","year":"2020","unstructured":"Harapan H, Itoh N, Yufika A, Winardi W, Keam S, Te H, et al. Coronavirus disease 2019 (COVID-19): a literature review. J Infect Public Health. 2020;13:667\u201373. https:\/\/doi.org\/10.1016\/j.jiph.2020.03.019.","journal-title":"J Infect Public Health"},{"key":"1410_CR2","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1080\/22221751.2020.1844552","volume":"9","author":"V Borges","year":"2020","unstructured":"Borges V, Isidro J, Cortes-Martins H, Duarte S, Vieira L, Leite R, et al. Massive dissemination of a SARS-CoV-2 Spike Y839 variant in Portugal. Emerg Microbes Infect. 2020;9:2488\u201396. https:\/\/doi.org\/10.1080\/22221751.2020.1844552.","journal-title":"Emerg Microbes Infect"},{"key":"1410_CR3","first-page":"2021","volume-title":"State of Health in the EU","author":"OECD, European observatory on healt","year":"2021","unstructured":"OECD, European observatory on health systems and policies. Portugal: Country Health Profile,. State of Health in the EU. Brussels: OECD Publishing; 2021. p. 2021."},{"key":"1410_CR4","unstructured":"National Institute of Health (INSA) Doutor Ricardo Jorge. Genomic epidemiology of novel coronavirus in Portugal from March 1st 2020 up to March 31st 2021. INSA 2021. https:\/\/insaflu.insa.pt\/ncov\/E-Mar2020-Mar202. Accessed February 20, 2023."},{"key":"1410_CR5","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/S41586-021-03677-Y","volume":"595","author":"EB Hodcroft","year":"2021","unstructured":"Hodcroft EB, Zuber M, Nadeau S, Vaughan TG, Crawford KHD, Althaus CL, et al. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020. Nature. 2021;595:707\u201312. https:\/\/doi.org\/10.1038\/S41586-021-03677-Y.","journal-title":"Nature"},{"key":"1410_CR6","unstructured":"World Health Organization. COVID-19 Strategy Update. 2020."},{"key":"1410_CR7","unstructured":"National Institute of Health (INSA) Doutor Ricardo Jorge. Genomic epidemiology of novel coronavirus in Portugal from February 1st 2021 up to November 30th 2021. INSA 2021. https:\/\/insaflu.insa.pt\/ncov\/D-Fev2021-Nov202. Accessed February 20, 2023."},{"key":"1410_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1140\/EPJP\/S13360-021-02321-Y","volume":"137","author":"A Gowrisankar","year":"2022","unstructured":"Gowrisankar A, Priyanka TMC, Banerjee S. Omicron: a mysterious variant of concern. Eur Phys J Plus. 2022;137:100. https:\/\/doi.org\/10.1140\/EPJP\/S13360-021-02321-Y.","journal-title":"Eur Phys J Plus"},{"key":"1410_CR9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/JOIM.13478","volume":"292","author":"A Vitiello","year":"2022","unstructured":"Vitiello A, Ferrara F, Auti AM, di Domenico M, Boccellino M. Advances in the Omicron variant development. J Intern Med. 2022;292:90. https:\/\/doi.org\/10.1111\/JOIM.13478.","journal-title":"J Intern Med"},{"key":"1410_CR10","unstructured":"National Institute of Health (INSA) Doutor Ricardo Jorge. Genomic epidemiology of novel coronavirus in Portugal from November 2021 to March 2022. INSA 2021. https:\/\/insaflu.insa.pt\/covid19\/."},{"key":"1410_CR11","unstructured":"National Institute of Health (INSA) Doutor Ricardo Jorge. Genomic epidemiology of novel coronavirus in Portugal from April 2022 to April 2023. INSA 2022. https:\/\/insaflu.insa.pt\/covid19\/."},{"key":"1410_CR12","unstructured":"National Institute of Health (INSA) Doutor Ricardo Jorge. Genetic diversity of the novel coronavirus SARS-CoV-2 (COVID-19) in Portugal - Situation Report, July 2024. Lisboa, Portugal INSA 2024. https:\/\/insaflu.insa.pt\/covid19\/."},{"key":"1410_CR13","unstructured":"Hodcroft EB. CoVariants: SARS-CoV-2 mutations and variants of interest 2020. https:\/\/covariants.org\/. Accessed September 9, 2024."},{"key":"1410_CR14","unstructured":"Dire\u00e7\u00e3o-Geral da Sa\u00fade. N\u00famero de Novos Casos e \u00d3bitos por Dia - COVID-19 2024. https:\/\/covid19.min-saude.pt\/numero-de-novos-casos-e-obitos-por-dia\/. Accessed September 10, 2024."},{"key":"1410_CR15","unstructured":"World Health Organization. COVID-19 Health System Response Monitor (HSRM) \u2013 Portugal. 2020. https:\/\/eurohealthobservatory.who.int\/monitors\/hsrm\/hsrm-countries\/hsrm\/portugal. Accessed September 9, 2024."},{"key":"1410_CR16","first-page":"8","volume":"I","author":"Portugal. Presidency of the Council of Ministers. Resolution of the Council of Ministers No. 181-A\/2021, 23","year":"2021","unstructured":"Portugal. Presidency of the Council of Ministers. Resolution of the Council of Ministers No. 181-A\/2021, 23. Di\u00e1rio da Rep\u00fablica No. 247\/2021, 1st Supplement. Series. December 2021;I:8\u201311.","journal-title":"Series"},{"key":"1410_CR17","first-page":"4","volume":"I","author":"Portugal. Presidency of the Council of Ministers. Resolution of the Council of Ministers No. 25-A\/2022, 18","year":"2022","unstructured":"Portugal. Presidency of the Council of Ministers. Resolution of the Council of Ministers No. 25-A\/2022, 18. Di\u00e1rio da Rep\u00fablica No. 35\/2022, 2nd Supplement. Series. February 2022;I:4\u201310.","journal-title":"Series"},{"key":"1410_CR18","doi-asserted-by":"publisher","unstructured":"Hu H, Du H, Li J, Wang Y, Wu X, Wang C, et al. Early prediction and identification for severe patients during the pandemic of COVID-19: a severe COVID-19 risk model constructed by multivariate logistic regression analysis. J Glob Health 2020;10. https:\/\/doi.org\/10.7189\/JOGH.10.020510.","DOI":"10.7189\/JOGH.10.020510"},{"key":"1410_CR19","doi-asserted-by":"publisher","unstructured":"Wynants L, Van Calster B, Collins GS, Riley RD, Heinze G, Schuit E, et al. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal. BMJ 2020;369. https:\/\/doi.org\/10.1136\/BMJ.M1328.","DOI":"10.1136\/BMJ.M1328"},{"key":"1410_CR20","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/ACEM.14447","volume":"29","author":"JL Miller","year":"2022","unstructured":"Miller JL, Tada M, Goto M, Chen H, Dang E, Mohr NM, et al. Prediction models for severe manifestations and mortality due to COVID-19: a systematic review. Acad Emerg Med. 2022;29:206\u201316. https:\/\/doi.org\/10.1111\/ACEM.14447.","journal-title":"Acad Emerg Med"},{"key":"1410_CR21","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jinf.2020.10.033","volume":"82","author":"S Saito","year":"2021","unstructured":"Saito S, Asai Y, Matsunaga N, Hayakawa K, Terada M, Ohtsu H, et al. First and second COVID-19 waves in Japan: a comparison of disease severity and characteristics. J Infect. 2021;82:84\u2013123. https:\/\/doi.org\/10.1016\/j.jinf.2020.10.033.","journal-title":"J Infect"},{"key":"1410_CR22","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1080\/20009666.2021.1949793","volume":"11","author":"MS Asghar","year":"2021","unstructured":"Asghar MS, Yasmin F, Ahsan MN, Alvi H, Taweesedt P, Surani S. Comparison of first and second waves of COVID-19 through severity markers in ICU patients of a developing country. J Community Hosp Intern Med Perspect. 2021;11:576. https:\/\/doi.org\/10.1080\/20009666.2021.1949793.","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"1410_CR23","doi-asserted-by":"publisher","first-page":"e0346","DOI":"10.1097\/CCE.0000000000000346","volume":"3","author":"I Mollinedo-Gajate","year":"2021","unstructured":"Mollinedo-Gajate I, Villar-\u00c1lvarez F, de los Zambrano-Chac\u00f3n M\u00c1, N\u00fa\u00f1ez-Garc\u00eda L, de la Due\u00f1a-Mu\u00f1oz L, L\u00f3pez-Chang C, et al. First and second waves of coronavirus disease 2019 in Madrid, Spain: clinical characteristics and hematological risk factors associated with critical\/fatal illness. Crit Care Explor. 2021;3. https:\/\/doi.org\/10.1097\/CCE.0000000000000346.","journal-title":"Crit Care Explor"},{"key":"1410_CR24","doi-asserted-by":"publisher","first-page":"e00008","DOI":"10.1128\/SPECTRUM.00008-22","volume":"10","author":"C Trobajo-Sanmart\u00edn","year":"2022","unstructured":"Trobajo-Sanmart\u00edn C, Mart\u00ednez-Baz I, Miqueleiz A, Fern\u00e1ndez-Huerta M, Burgui C, Casado I, et al. Differences in transmission between SARS-CoV-2 alpha (B.1.1.7) and delta (B.1.617.2) Variants. Microbiol Spectr. 2022;10:e00008-22. https:\/\/doi.org\/10.1128\/SPECTRUM.00008-22.","journal-title":"Microbiol Spectr"},{"key":"1410_CR25","doi-asserted-by":"publisher","first-page":"15456","DOI":"10.1038\/S41598-022-19125-4","volume":"12","author":"D Florensa","year":"2022","unstructured":"Florensa D, Mateo J, Spaimoc R, Miret C, Godoy S, Solsona F, et al. Severity of COVID-19 cases in the months of predominance of the Alpha and Delta variants. Sci Rep. 2022;12:15456. https:\/\/doi.org\/10.1038\/S41598-022-19125-4.","journal-title":"Sci Rep"},{"key":"1410_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12879-022-07909-y","volume":"22","author":"R Amin","year":"2022","unstructured":"Amin R, Sohrabi MR, Zali AR, Hannani K. Five consecutive epidemiological waves of COVID-19: a population-based cross-sectional study on characteristics, policies, and health outcome. BMC Infect Dis. 2022;22:1\u201310. https:\/\/doi.org\/10.1186\/S12879-022-07909-y.","journal-title":"BMC Infect Dis"},{"key":"1410_CR27","unstructured":"National Institute of Health (INSA) Doutor Ricardo Jorge. Genetic diversity of the novel coronavirus SARS-CoV-2 (COVID-19) in Portugal. INSA 2023. https:\/\/insaflu.insa.pt\/covid19\/. Accessed February 20, 2023."},{"key":"1410_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/MEDICINA60010059\/S1","volume":"60","author":"CP Von Rekowski","year":"2024","unstructured":"Von Rekowski CP, Fonseca TAH, Ara\u00fajo R, Br\u00e1s-Geraldes C, Calado CRC, Bento L, et al. The Characteristics and Laboratory Findings of SARS-CoV-2 Infected Patients during the First Three COVID-19 Waves in Portugal\u2014a Retrospective Single-Center Study. Medicina (B Aires). 2024;60:59. https:\/\/doi.org\/10.3390\/MEDICINA60010059\/S1.","journal-title":"Medicina (B Aires)"},{"key":"1410_CR29","unstructured":"Servi\u00e7o Nacional de Sa\u00fade (SNS). Plano de vacina\u00e7\u00e3o contra a Covid-19. Governo Da Rep\u00fablica Portuguesa - Minist\u00e9rio Da Sa\u00fade, 2021. https:\/\/www.sns.gov.pt. Accessed July 10, 2023."},{"key":"1410_CR30","doi-asserted-by":"publisher","first-page":"289","DOI":"10.5492\/WJCCM.V10.I5.278","volume":"10","author":"A Gkoufa","year":"2021","unstructured":"Gkoufa A, Maneta E, Ntoumas GN, Georgakopoulou VE, Mantelou A, Kokkoris S, et al. Elderly adults with COVID-19 admitted to intensive care unit: a narrative review. World J Crit Care Med. 2021;10:289. https:\/\/doi.org\/10.5492\/WJCCM.V10.I5.278.","journal-title":"World J Crit Care Med"},{"key":"1410_CR31","doi-asserted-by":"publisher","unstructured":"Zhang J jin, Dong X, Liu G hui, Gao Y dong. Risk and protective factors for COVID-19 morbidity, severity, and mortality. Clin Rev Allergy Immunol 2022;64:90\u2013107. https:\/\/doi.org\/10.1007\/S12016-022-08921-5.","DOI":"10.1007\/S12016-022-08921-5"},{"key":"1410_CR32","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/JMV.27293","volume":"94","author":"HM Zawbaa","year":"2022","unstructured":"Zawbaa HM, Osama H, El-Gendy A, Saeed H, Harb HS, Madney YM, et al. Effect of mutation and vaccination on spread, severity, and mortality of COVID-19 disease. J Med Virol. 2022;94:204. https:\/\/doi.org\/10.1002\/JMV.27293.","journal-title":"J Med Virol"},{"issue":"6","key":"1410_CR33","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41573-023-00672-y","volume":"22","author":"G Li","year":"2023","unstructured":"Li G, Hilgenfeld R, Whitley R, De Clercq E. Therapeutic strategies for COVID-19: progress and lessons learned. Nat Rev Drug Discov. 2023;22(6):449\u201375. https:\/\/doi.org\/10.1038\/s41573-023-00672-y.","journal-title":"Nat Rev Drug Discov"},{"key":"1410_CR34","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/S40265-023-01926-0","volume":"83","author":"HA Blair","year":"2023","unstructured":"Blair HA. Remdesivir: a review in COVID-19. Drugs. 2023;83:1237. https:\/\/doi.org\/10.1007\/S40265-023-01926-0.","journal-title":"Drugs"},{"key":"1410_CR35","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","volume":"395","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020;395:1569\u201378. https:\/\/doi.org\/10.1016\/S0140-6736(20)31022-9.","journal-title":"Lancet"},{"key":"1410_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-22145-9","volume":"12","author":"S Iftimie","year":"2022","unstructured":"Iftimie S, L\u00f3pez-Azcona AF, Lozano-Olmo MJ, Hern\u00e1ndez-Aguilera A, Sarr\u00e0-Moret\u00f3 S, Joven J, et al. Characteristics of hospitalized patients with SARS-CoV-2 infection during successive waves of the COVID-19 pandemic in a reference hospital in Spain. Sci Rep. 2022;12:1\u20138. https:\/\/doi.org\/10.1038\/s41598-022-22145-9.","journal-title":"Sci Rep"},{"key":"1410_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12879-022-07941-Y\/TABLES\/2","volume":"23","author":"C Anscombe","year":"2023","unstructured":"Anscombe C, Lissauer S, Thole H, Rylance J, Dula D, Menyere M, et al. A comparison of four epidemic waves of COVID-19 in Malawi; an observational cohort study. BMC Infect Dis. 2023;23:1\u20139. https:\/\/doi.org\/10.1186\/S12879-022-07941-Y\/TABLES\/2.","journal-title":"BMC Infect Dis"},{"key":"1410_CR38","doi-asserted-by":"publisher","first-page":"E0653","DOI":"10.1097\/CCE.0000000000000653","volume":"4","author":"P Tandon","year":"2022","unstructured":"Tandon P, Leibner ES, Hackett A, Maguire K, Mashriqi N, Kohli-Seth R. The third wave: comparing seasonal trends in COVID-19 patient data at a large hospital system in New York City. Crit Care Explor. 2022;4:E0653. https:\/\/doi.org\/10.1097\/CCE.0000000000000653.","journal-title":"Crit Care Explor"},{"key":"1410_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/HSR2.603","volume":"5","author":"EKC Wong","year":"2022","unstructured":"Wong EKC, Watt J, Zou H, Chandraraj A, Zhang AW, Norman R, et al. Mortality in hospitalized older adults with COVID-19 during three waves: a multicenter retrospective cohort study. Health Sci Rep. 2022;5: e603. https:\/\/doi.org\/10.1002\/HSR2.603.","journal-title":"Health Sci Rep"},{"key":"1410_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/J.BJID.2024.103737","volume":"28","author":"DE Rebell\u00f3n-S\u00e1nchez","year":"2024","unstructured":"Rebell\u00f3n-S\u00e1nchez DE, Guzm\u00e1n TM, Rodriguez S, Llanos-Torres J, Vinueza D, Tafurt E, et al. Navigating the waves in Colombia: a cohort study of inpatient care during four COVID-19 waves. Braz J Infect Dis. 2024;28: 103737. https:\/\/doi.org\/10.1016\/J.BJID.2024.103737.","journal-title":"Braz J Infect Dis"},{"key":"1410_CR41","doi-asserted-by":"publisher","unstructured":"Contou D, Fraiss\u00e9 M, Pajot O, Tirolien JA, Mentec H, Plantef\u00e8ve G. Comparison between first and second wave among critically ill COVID-19 patients admitted to a French ICU: no prognostic improvement during the second wave? Crit Care 2021;25. https:\/\/doi.org\/10.1186\/S13054-020-03449-6.","DOI":"10.1186\/S13054-020-03449-6"},{"key":"1410_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12879-022-07413-3\/TABLES\/4","volume":"22","author":"HN Buttensch\u00f8n","year":"2022","unstructured":"Buttensch\u00f8n HN, Lynggaard V, Sandb\u00f8l SG, Glassou EN, Haagerup A. Comparison of the clinical presentation across two waves of COVID-19: a retrospective cohort study. BMC Infect Dis. 2022;22:1\u201311. https:\/\/doi.org\/10.1186\/S12879-022-07413-3\/TABLES\/4.","journal-title":"BMC Infect Dis"},{"key":"1410_CR43","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/S13613-021-00825-5","volume":"11","author":"N Bonnet","year":"2021","unstructured":"Bonnet N, Martin O, Boubaya M, Levy V, Ebstein N, Karoubi P, et al. High flow nasal oxygen therapy to avoid invasive mechanical ventilation in SARS-CoV-2 pneumonia: a retrospective study. Ann Intensive Care. 2021;11:37. https:\/\/doi.org\/10.1186\/S13613-021-00825-5.","journal-title":"Ann Intensive Care"},{"key":"1410_CR44","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1001\/JAMA.2021.20714","volume":"326","author":"GA Ospina-Tasc\u00f3n","year":"2021","unstructured":"Ospina-Tasc\u00f3n GA, Calder\u00f3n-Tapia LE, Garc\u00eda AF, Zarama V, G\u00f3mez-\u00c1lvarez F, \u00c1lvarez-Saa T, et al. Effect of high-flow oxygen therapy vs conventional oxygen therapy on invasive mechanical ventilation and clinical recovery in patients with severe COVID-19: a randomized clinical trial. JAMA. 2021;326:2161\u201371. https:\/\/doi.org\/10.1001\/JAMA.2021.20714.","journal-title":"JAMA"},{"key":"1410_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13613-023-01238-2\/FIGURES\/2","volume":"14","author":"F Termorshuizen","year":"2024","unstructured":"Termorshuizen F, Dongelmans DA, Brinkman S, Bakhshi-Raiez F, Arbous MS, de Lange DW, et al. Characteristics and outcome of COVID-19 patients admitted to the ICU: a nationwide cohort study on the comparison between the consecutive stages of the COVID-19 pandemic in the Netherlands, an update. Ann Intensive Care. 2024;14:1\u201312. https:\/\/doi.org\/10.1186\/S13613-023-01238-2\/FIGURES\/2.","journal-title":"Ann Intensive Care"},{"key":"1410_CR46","doi-asserted-by":"publisher","unstructured":"Ricoca Peixoto V, Vieira A, Aguiar P, Carvalho C, Rhys Thomas D, Abrantes A. Initial assessment of the impact of the emergency state lockdown measures on the 1st wave of the COVID-19 epidemic in Portugal. Acta Med Port 2020;33:733\u201341. https:\/\/doi.org\/10.20344\/AMP.14129.","DOI":"10.20344\/AMP.14129"},{"key":"1410_CR47","doi-asserted-by":"publisher","unstructured":"OECD, European observatory on health systems and policies. Portugal: Country Health Profile 2023. State of Health in the EU, Brussels: OECD Publishing; 2023. https:\/\/doi.org\/10.1787\/069af7b1-en.","DOI":"10.1787\/069af7b1-en"},{"key":"1410_CR48","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000031154","volume":"101","author":"S Zambrano","year":"2022","unstructured":"Zambrano S, Davis M, Leeds DR, Noronha K, McLaughlin A, Burns RH, et al. Laboratory test trends within 72 hours of hospital admission associated with death among COVID-19 patients. Medicine. 2022;101: e31154. https:\/\/doi.org\/10.1097\/MD.0000000000031154.","journal-title":"Medicine"},{"key":"1410_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0275131","volume":"17","author":"TA Mezgebu","year":"2022","unstructured":"Mezgebu TA, Sibhat MM, Getnet MT, Gebeyehu KT, Chane WZ, Getahun EM, et al. Risk factors of early mortality among COVID-19 deceased patients in Addis Ababa COVID-19 care centers. Ethiopia PLoS One. 2022;17: e0275131. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0275131.","journal-title":"Ethiopia PLoS One"},{"key":"1410_CR50","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.3390\/IJERPH19063357\/S1","volume":"19","author":"YF Yen","year":"2022","unstructured":"Yen YF, Chan SY, Chen CC, Deng CY. Predictors for Early and Late Death in Adult Patients with COVID-19: a Cohort Study. Int J Environ Res Public Health. 2022;19:3357. https:\/\/doi.org\/10.3390\/IJERPH19063357\/S1.","journal-title":"Int J Environ Res Public Health"},{"key":"1410_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12879-024-09592-7\/","volume":"24","author":"D Lipski","year":"2024","unstructured":"Lipski D, Radziemski A, Wasiliew S, Wyrwa M, Szczepaniak-Chiche\u0142 L, Stryczy\u0144ski \u0141, et al. Assessment of COVID-19 risk factors of early and long-term mortality with prediction models of clinical and laboratory variables. BMC Infect Dis. 2024;24:1\u20139. https:\/\/doi.org\/10.1186\/S12879-024-09592-7\/.","journal-title":"BMC Infect Dis"},{"key":"1410_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/J.LANA.2022.100244","volume":"11","author":"H Perazzo","year":"2022","unstructured":"Perazzo H, Cardoso SW, Ribeiro MPD, Moreira R, Coelho LE, Jalil EM, et al. In-hospital mortality and severe outcomes after hospital discharge due to COVID-19: a prospective multicenter study from Brazil. Lancet Reg Health Am. 2022;11: 100244. https:\/\/doi.org\/10.1016\/J.LANA.2022.100244.","journal-title":"Lancet Reg Health Am"},{"key":"1410_CR53","doi-asserted-by":"publisher","first-page":"144","DOI":"10.4103\/IJMR.IJMR_973_23","volume":"158","author":"G Kumar","year":"2023","unstructured":"Kumar G, Talukdar A, Turuk A, Bhalla A, Mukherjee S, Bhardwaj P, et al. Determinants of post discharge mortality among hospitalized COVID-19 patients. Indian J Med Res. 2023;158:144. https:\/\/doi.org\/10.4103\/IJMR.IJMR_973_23.","journal-title":"Indian J Med Res"},{"key":"1410_CR54","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1001\/JAMAINTERNMED.2023.3587","volume":"183","author":"TJ Iwashyna","year":"2023","unstructured":"Iwashyna TJ, Seelye S, Berkowitz TS, Pura J, Bohnert ASB, Bowling CB, et al. Late mortality after COVID-19 infection among US veterans vs risk-matched comparators: a 2-year cohort analysis. JAMA Intern Med. 2023;183:1119. https:\/\/doi.org\/10.1001\/JAMAINTERNMED.2023.3587.","journal-title":"JAMA Intern Med"},{"key":"1410_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13054-021-03492-x","volume":"25","author":"D Contou","year":"2021","unstructured":"Contou D, Cally R, Sarfati F, Desaint P, Fraiss\u00e9 M, Plantef\u00e8ve G. Causes and timing of death in critically ill COVID-19 patients. Crit Care. 2021;25:1\u20134. https:\/\/doi.org\/10.1186\/S13054-021-03492-x.","journal-title":"Crit Care"},{"key":"1410_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13054-021-03639-w","volume":"25","author":"C de Roquetaillade","year":"2021","unstructured":"de Roquetaillade C, Bredin S, Lascarrou JB, Soumagne T, Cojocaru M, Chousterman BG, et al. Timing and causes of death in severe COVID-19 patients. Crit Care. 2021;25:1\u20138. https:\/\/doi.org\/10.1186\/S13054-021-03639-w.","journal-title":"Crit Care"},{"key":"1410_CR57","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41591-022-02156-9","volume":"29","author":"CD Russell","year":"2023","unstructured":"Russell CD, Lone NI, Baillie JK. Comorbidities, multimorbidity and COVID-19. Nat Med. 2023;29:334\u201343. https:\/\/doi.org\/10.1038\/s41591-022-02156-9.","journal-title":"Nat Med"},{"key":"1410_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/J.SMHL.2020.100178","volume":"20","author":"M Pourhomayoun","year":"2021","unstructured":"Pourhomayoun M, Shakibi M. Predicting mortality risk in patients with COVID-19 using machine learning to help medical decision-making. Smart Health. 2021;20: 100178. https:\/\/doi.org\/10.1016\/J.SMHL.2020.100178.","journal-title":"Smart Health"},{"key":"1410_CR59","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1080\/00325481.2020.1786964","volume":"132","author":"MS Gold","year":"2020","unstructured":"Gold MS, Sehayek D, Gabrielli S, Zhang X, McCusker C, Ben-Shoshan M. COVID-19 and comorbidities: a systematic review and meta-analysis. Postgrad Med. 2020;132:749\u201355. https:\/\/doi.org\/10.1080\/00325481.2020.1786964.","journal-title":"Postgrad Med"},{"key":"1410_CR60","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1021\/ACSPTSCI.2C00181","volume":"6","author":"S Chatterjee","year":"2023","unstructured":"Chatterjee S, Nalla LV, Sharma M, Sharma N, Singh AA, Malim FM, et al. Association of COVID-19 with comorbidities: an update. ACS Pharmacol Transl Sci. 2023;6:354. https:\/\/doi.org\/10.1021\/ACSPTSCI.2C00181.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"1410_CR61","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/S11739-021-02784-y","volume":"17","author":"S Ba\u015fc\u0131","year":"2022","unstructured":"Ba\u015fc\u0131 S, Ata N, Altunta\u015f F, Yi\u011feno\u011flu TN, Dal MS, Korkmaz S, et al. Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers. Intern Emerg Med. 2022;17:135\u20139. https:\/\/doi.org\/10.1007\/S11739-021-02784-y.","journal-title":"Intern Emerg Med"},{"key":"1410_CR62","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/S10238-023-01004-5","volume":"23","author":"N Hardy","year":"2023","unstructured":"Hardy N, Vegivinti CTR, Mehta M, Thurnham J, Mebane A, Pederson JM, et al. Mortality of COVID-19 in patients with hematological malignancies versus solid tumors: a systematic literature review and meta-analysis. Clin Exp Med. 2023;23:15. https:\/\/doi.org\/10.1007\/S10238-023-01004-5.","journal-title":"Clin Exp Med"},{"key":"1410_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/J.HELIYON.2024.E27251","volume":"10","author":"S Montero","year":"2024","unstructured":"Montero S, Magui\u00f1a JL, Soto-Becerra P, Failoc-Rojas VE, Chira-Sosa J, Apolaya-Segura M, et al. Laboratory biomarkers associated with COVID-19 mortality among inpatients in a Peruvian referral hospital. Heliyon. 2024;10: e27251. https:\/\/doi.org\/10.1016\/J.HELIYON.2024.E27251.","journal-title":"Heliyon"},{"key":"1410_CR64","doi-asserted-by":"publisher","unstructured":"Tong-Minh K, van der Does Y, van Rosmalen J, Ramakers C, Gommers D, van Gorp E, et al. Joint modeling of repeated measurements of different biomarkers predicts mortality in COVID-19 patients in the intensive care unit. Biomark Insights 2022;17. https:\/\/doi.org\/10.1177\/11772719221112370.","DOI":"10.1177\/11772719221112370"},{"key":"1410_CR65","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3390\/LIFE14030343","volume":"14","author":"M Di Maso","year":"2024","unstructured":"Di Maso M, Delbue S, Sampietro M, Ferraroni M, Modenese A, Dolci M, et al. Assessing the association between biomarkers and COVID-19 mortality using the joint modelling approach. Life. 2024;14:343. https:\/\/doi.org\/10.3390\/LIFE14030343.","journal-title":"Life"},{"key":"1410_CR66","doi-asserted-by":"publisher","DOI":"10.1136\/BMJOPEN-2020-041295","volume":"10","author":"G Hodges","year":"2020","unstructured":"Hodges G, Pallisgaard J, Schjerning Olsen AM, McGettigan P, Andersen M, Krogager M, et al. Association between biomarkers and COVID-19 severity and mortality: a nationwide Danish cohort study. BMJ Open. 2020;10: e041295. https:\/\/doi.org\/10.1136\/BMJOPEN-2020-041295.","journal-title":"BMJ Open"},{"key":"1410_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.chstcc.2023.100035","volume":"2","author":"S Isha","year":"2024","unstructured":"Isha S, Satashia P, Raavi L, Jonna S, Jenkins A, Hanson AJ, et al. Procalcitonin levels and bacterial coinfection in hospitalized patients with COVID-19. CHEST Critical Care. 2024;2: 100035. https:\/\/doi.org\/10.1016\/j.chstcc.2023.100035.","journal-title":"CHEST Critical Care"},{"key":"1410_CR68","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0272840","volume":"17","author":"A Kumar","year":"2022","unstructured":"Kumar A, Karn E, Trivedi K, Kumar P, Chauhan G, Kumari A, et al. Procalcitonin as a predictive marker in COVID-19: a systematic review and meta-analysis. PLoS ONE. 2022;17: e0272840. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0272840.","journal-title":"PLoS ONE"},{"key":"1410_CR69","doi-asserted-by":"publisher","unstructured":"Relph KA, Russell CD, Fairfield CJ, Turtle L, De Silva TI, Siggins MK, et al. Procalcitonin is not a reliable biomarker of bacterial coinfection in people with coronavirus disease 2019 undergoing microbiological investigation at the time of hospital admission. Open Forum Infect Dis 2022;9:ofac179. https:\/\/doi.org\/10.1093\/OFID\/OFAC179.","DOI":"10.1093\/OFID\/OFAC179"},{"key":"1410_CR70","doi-asserted-by":"publisher","unstructured":"Alsrhani A, Alshomar A, Elderdery AY, Rasheed Z, Farhana A. Diagnosis and stratification of COVID-19 infections using differential plasma levels of D-dimer: a two-center study from Saudi Arabia. Microbiol Res 2023, Vol 14, Pages 67\u201376 2023;14:67\u201376. https:\/\/doi.org\/10.3390\/MICROBIOLRES14010006.","DOI":"10.3390\/MICROBIOLRES14010006"},{"key":"1410_CR71","doi-asserted-by":"publisher","unstructured":"Neto AL de S, Mendes-Rodrigues C, Pedroso R dos S, R\u00f6der DVD de B. Revisiting the COVID-19 pandemic: mortality and predictors of death in adult patients in the intensive care unit. Life 2024;14:1027. https:\/\/doi.org\/10.3390\/LIFE14081027.","DOI":"10.3390\/LIFE14081027"},{"key":"1410_CR72","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/J.TOXREP.2023.10.003","volume":"11","author":"F Ostadi","year":"2023","unstructured":"Ostadi F, Anzali BC, Mehryar HR. Relationship between serum lactate dehydrogenase levels and prognosis in patients infected with omicron and delta variants of COVID-19: a cross-sectional study. Toxicol Rep. 2023;11:368\u201373. https:\/\/doi.org\/10.1016\/J.TOXREP.2023.10.003.","journal-title":"Toxicol Rep"},{"key":"1410_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-28201-2","volume":"13","author":"K Kojima","year":"2023","unstructured":"Kojima K, Yoon H, Okishio K, Tsuyuguchi K. Increased lactate dehydrogenase reflects the progression of COVID-19 pneumonia on chest computed tomography and predicts subsequent severe disease. Sci Rep. 2023;13:1\u201310. https:\/\/doi.org\/10.1038\/s41598-023-28201-2.","journal-title":"Sci Rep"},{"key":"1410_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2021.720363","volume":"12","author":"YY Luan","year":"2021","unstructured":"Luan YY, Yin CH, Yao YM. Update advances on C-reactive protein in COVID-19 and other viral infections. Front Immunol. 2021;12: 720363. https:\/\/doi.org\/10.3389\/FIMMU.2021.720363.","journal-title":"Front Immunol"},{"key":"1410_CR75","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1097\/MS9.0000000000000761","volume":"85","author":"AJ Abdullah","year":"2023","unstructured":"Abdullah AJ, Arif AT, Rahman HA, Sofihussein KQ, Hadi JM, Aziz JMA, et al. Assessing serum C-reactive protein as a predictor of COVID-19 outcomes: a retrospective cross-sectional study. Ann Med Surg. 2023;85:3363. https:\/\/doi.org\/10.1097\/MS9.0000000000000761.","journal-title":"Ann Med Surg"},{"key":"1410_CR76","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.3390\/JCM11144112","volume":"11","author":"A Boccatonda","year":"2022","unstructured":"Boccatonda A, D\u2019Ardes D, Rossi I, Grignaschi A, Lanotte A, Cipollone F, et al. Platelet count in patients with SARS-CoV-2 infection: a prognostic factor in COVID-19. J Clin Med. 2022;11:4112. https:\/\/doi.org\/10.3390\/JCM11144112.","journal-title":"J Clin Med"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-024-01410-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-024-01410-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-024-01410-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T21:18:56Z","timestamp":1744492736000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-024-01410-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":76,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["1410"],"URL":"https:\/\/doi.org\/10.1007\/s11357-024-01410-x","relation":{},"ISSN":["2509-2723"],"issn-type":[{"type":"electronic","value":"2509-2723"}],"subject":[],"published":{"date-parts":[[2024,11,14]]},"assertion":[{"value":"2 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the institutional Ethics Committee of Unidade Local de Sa\u00fade S\u00e3o Jos\u00e9 (ULSSJ), Lisbon, Portugal, specifically Comiss\u00e3o de \u00c9tica para a Sa\u00fade, on 20 May 2020 (number 1043\/2021), in the scope of the Predictive Models of COVID-19 Outcomes for Higher Risk Patients Towards a Precision Medicine (PREMO) project.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all subjects involved in the study and approval was obtained before collecting any data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}